Assessing telomeric DNA content in pediatric cancers using whole-genome sequencing data.
Genome Biol
13:
2012
R113
|
23
|
Genomic landscape of paediatric adrenocortical tumours.
Nat Commun
6:
2015
6302
|
110
|
ATRX mutations and glioblastoma: Impaired DNA damage repair, alternative lengthening of telomeres, and genetic instability.
Mol Cell Oncol
3:
2016
e1167158
|
34
|
Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma.
Oncotarget
7:
2016
65696-65706
|
43
|
Identification of potentially oncogenic alterations from tumor-only samples reveals Fanconi anemia pathway mutations in bladder carcinomas.
NPJ Genom Med
2:
2017
29
|
8
|
H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers.
Elife
7:
2018
e36696
|
52
|
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells.
Nat Med
24:
2018
1204-1215
|
102
|
Structure and evolution of double minutes in diagnosis and relapse brain tumors.
Acta Neuropathol
137:
2019
123-137
|
50
|
Landscape of Germline and Somatic Mitochondrial DNA Mutations in Pediatric Malignancies.
Cancer Res
79:
2019
1318-1330
|
28
|
Germline Variants in Phosphodiesterase Genes and Genetic Predisposition to Pediatric Adrenocortical Tumors.
Cancers (Basel)
12:
2020
E506
|
14
|
CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data.
Genome Biol
21:
2020
126
|
57
|
The evolution of relapse of adult T cell acute lymphoblastic leukemia.
Genome Biol
21:
2020
284
|
8
|
The landscape of coding RNA editing events in pediatric cancer.
BMC Cancer
21:
2021
1233
|
6
|
Structural variants shape driver combinations and outcomes in pediatric high-grade glioma.
Nat Cancer
3:
2022
994-1011
|
18
|
Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.
Nat Cancer
4:
2023
276-289
|
17
|
Aberrant DNA repair reveals a vulnerability in histone H3.3-mutant brain tumors.
Nucleic Acids Res
52:
2024
2372-2388
|
3
|
Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma.
Nat Commun
15:
2024
8983
|
0
|